360-Degree View of the Tomato

Researchers have sequenced 360 varieties of the tomato plant to create a comprehensive map of the evolution of the fruit from its wild form to the modern varieties.

Written byAnna Azvolinsky
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The three evolutionary stages of tomatoes. From the left to right: Solanum pimpinellifolium, S. lycopersicum var. cerasiforme and S. lycopersicum.INSTITUTE OF VEGETABLES AND FLOWERS IN THE CHINESE ACADEMY OF AGRICULTURAL SCIENCES, BEIJING, CHINAThe typical red, modern tomato is about one hundred times bigger than its pea-sized wild ancestor, which originally came from the Andes region in South America. To track the long history of tomato breeding and understand how such human-imposed selection has changed the genome of the plant, an international team of researchers, have sequenced 360 tomato plant varieties, including wild and domesticated species. The results are published today (October 12) in Nature Genetics.

“Two years ago we only had one genome and now we have more than 300!” said Harry Klee, a horticultural scientist at the University of Florida who studies tomatoes and was not involved in the current study. “What makes this work really important is that it’s a foundation for future improvements on the tomato. We can now find causative genes for the traits we want. This is going to have a huge impact for tomato breeding very quickly.”

The large-scale effort, led by Sanwen Huang of the Institute of Vegetables and Flowers at the Chinese Academy of Agricultural Sciences in Beijing, China, has uncovered a signature of the modern, processing tomato used to make ketchup, a variant that gives some tomato varieties a pink color, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies